KRG-3332

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKRG-3332
Drug Alias NameKRG-3332
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A